March 12, 2018 / 12:18 PM / 2 months ago

BRIEF-Eiger Biopharmaceuticals Q4 Loss Per Share $1.11

March 12 (Reuters) - Eiger Biopharmaceuticals Inc:

* EIGER BIOPHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $1.11

* Q4 EARNINGS PER SHARE VIEW $-1.02 — THOMSON REUTERS I/B/E/S

* ‍CASH RUNWAY EXTENDS THROUGH MID-2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below